Listed

Boston Scientific Corp: Form 10-Q for the period ended Jun 30, 2019

Filed with the SEC on Jul 30, 2019 and accepted by EDGAR at Jul 30, 2019, 20:11 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-04-01 to 2019-06-30$2.63bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2019-01-01 to 2019-06-30$5.12bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-04-01 to 2019-06-30$758.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2019-01-01 to 2019-06-30$1.49bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-04-01 to 2019-06-30$1.87bnus-gaap:GrossProfit
Gross profit6 months2019-01-01 to 2019-06-30$3.64bnus-gaap:GrossProfit
Selling, general and administrative3 months2019-04-01 to 2019-06-30$968.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2019-01-01 to 2019-06-30$1.84bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-04-01 to 2019-06-30$384.0mus-gaap:OperatingIncomeLoss
Operating income6 months2019-01-01 to 2019-06-30$925.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-04-01 to 2019-06-30$89.0mus-gaap:InterestExpense
Interest expense6 months2019-01-01 to 2019-06-30$198.0mus-gaap:InterestExpense
Income tax3 months2019-04-01 to 2019-06-30−$9.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2019-01-01 to 2019-06-30$24.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-04-01 to 2019-06-30$154.0mus-gaap:ProfitLoss
Net income6 months2019-01-01 to 2019-06-30$578.0mus-gaap:ProfitLoss
Diluted EPS3 months2019-04-01 to 2019-06-30$0.11us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2019-01-01 to 2019-06-30$0.41us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-04-01 to 2019-06-30$0.11us-gaap:EarningsPerShareBasic
Basic EPS6 months2019-01-01 to 2019-06-30$0.42us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-04-01 to 2019-06-301,408,600,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2019-01-01 to 2019-06-301,408,500,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2019-01-01 to 2019-06-30$642.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-01-01 to 2019-06-30$154.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-06-30$123.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-06-30$6.33bnus-gaap:AssetsCurrent
Total assetsAt period end2019-06-30$24.31bnus-gaap:Assets
Current liabilitiesAt period end2019-06-30$4.85bnus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2019-06-30$1.95bnus-gaap:DebtCurrent
Shareholders' equityAt period end2019-06-30$9.43bnus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0000885725-19-000040. Last ingested by Listed: Nov 6, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.